DCP as a biomarker for TACE efficacy in hepatocellular carcinoma
{{output}}
Introduction: Primary hepatocellular carcinoma (PHC) requires advanced diagnostic and therapeutic strategies. While transcatheter arterial chemoembolization (TACE) is a cornerstone treatment, efficacy assessment remains challengi... ...
